Shares of Celcuity Inc (NASDAQ:CELC) have received a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.
Brokerages have set a twelve-month consensus price target of $36.00 for the company and are expecting that the company will post ($0.22) earnings per share for the current quarter, according to Zacks. Zacks has also given Celcuity an industry rank of 74 out of 255 based on the ratings given to related companies.
A number of analysts have recently commented on the company. Zacks Investment Research raised Celcuity from a “hold” rating to a “buy” rating and set a $26.00 target price on the stock in a research report on Thursday, February 28th. ValuEngine upgraded Celcuity from a “hold” rating to a “buy” rating in a report on Friday, March 15th. Finally, HC Wainwright set a $36.00 price target on Celcuity and gave the company a “buy” rating in a report on Monday, December 10th.
Celcuity (NASDAQ:CELC) last announced its earnings results on Tuesday, February 26th. The company reported ($0.18) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.02. As a group, sell-side analysts forecast that Celcuity will post -0.86 EPS for the current fiscal year.
Hedge funds and other institutional investors have recently modified their holdings of the business. Northern Trust Corp lifted its position in shares of Celcuity by 176.0% during the 2nd quarter. Northern Trust Corp now owns 57,670 shares of the company’s stock worth $1,432,000 after purchasing an additional 36,774 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Celcuity by 32.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 15,483 shares of the company’s stock worth $445,000 after purchasing an additional 3,761 shares during the last quarter. BlackRock Inc. lifted its position in shares of Celcuity by 1.6% during the 3rd quarter. BlackRock Inc. now owns 291,411 shares of the company’s stock worth $8,381,000 after purchasing an additional 4,604 shares during the last quarter. Renaissance Technologies LLC acquired a new position in Celcuity in the 3rd quarter valued at approximately $336,000. Finally, Teachers Advisors LLC acquired a new position in Celcuity in the 3rd quarter valued at approximately $207,000. Hedge funds and other institutional investors own 21.93% of the company’s stock.
Celcuity Inc, a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the clinical outcomes of cancer patients treated with targeted therapies in the United States. The company's CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.